In a filing, Meta Platforms Inc revealed its Director KIMMITT ROBERT M acquired Company’s shares for reported $0.34 million on Jul 15 ’25. In the deal valued at $723.08 per share,465 shares were bought.
Then, Newstead Jennifer bought 519 shares, generating $375,279 in total proceeds.
Before that, Olivan Javier bought 517 shares. Meta Platforms Inc shares valued at $370,948 were divested by the Officer at a price of $717.50 per share.
Needham upgraded its Meta Platforms Inc [META] rating to a Hold from a an Underperform in a research note published recently. A number of analysts have revised their coverage, including UBS’s analysts, who remained covering the stock and in late June has reiterated a ‘”a Buy”‘ rating for it. Citigroup also remained covering META and reiterated its “Buy” recommendation on June 24, 2025. Wedbush maintained its rating on May 01, 2025. It rated META as “an Outperform”.
Price Performance Review of META
On Tuesday, Meta Platforms Inc [NASDAQ:META] saw its stock fall -1.46% to $710.39. Over the last five days, the stock has lost -1.43%. Meta Platforms Inc shares have risen nearly 38.56% since the year began. Nevertheless, the stocks have risen 21.33% over the past one year. While a 52-week high of $747.90 was reached on 06/30/25, a 52-week low of $442.65 was recorded on 04/21/25.
Levels Of Support And Resistance For META Stock
The 24-hour chart illustrates a support level at 705.32, which if violated will result in even more drops to 700.24. On the upside, there is a resistance level at 719.97. A further resistance level may holdings at 729.55.
How much short interest is there in Meta Platforms Inc?
A steep rise in short interest was recorded in Meta Platforms Inc stocks on 2025-06-13, dropping by -5.44 million shares to a total of 30.14 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 35.57 million shares. There was a decline of -18.03%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on May 01, 2025 when UBS resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $683.
